{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T16:40:10Z","timestamp":1648831210692},"reference-count":25,"publisher":"American Association of Avian Pathologists (AAAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Avian Diseases"],"published-print":{"date-parts":[[2020,1,14]]},"DOI":"10.1637\/aviandiseases-d-19-00166","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T12:18:19Z","timestamp":1604578699000},"source":"Crossref","is-referenced-by-count":0,"title":["Codon Deoptimization of UL54 in meq-Deleted Marek's Disease Vaccine Candidate Eliminates Lymphoid Atrophy but Reduces Vaccinal Protection"],"prefix":"10.1637","volume":"64","author":[{"given":"Steven J.","family":"Conrad","sequence":"first","affiliation":[{"name":"United States Department of Agriculture, Agricultural Research Service, U.S. National Poultry Research Center, Avian Disease and Oncology Laboratory, East Lansing, MI 48823"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cari J.","family":"Hearn","sequence":"additional","affiliation":[{"name":"United States Department of Agriculture, Agricultural Research Service, U.S. National Poultry Research Center, Avian Disease and Oncology Laboratory, East Lansing, MI 48823"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert F.","family":"Silva","sequence":"additional","affiliation":[{"name":"United States Department of Agriculture, Agricultural Research Service, U.S. National Poultry Research Center, Avian Disease and Oncology Laboratory, East Lansing, MI 48823"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Dunn","sequence":"additional","affiliation":[{"name":"United States Department of Agriculture, Agricultural Research Service, U.S. National Poultry Research Center, Avian Disease and Oncology Laboratory, East Lansing, MI 48823"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1212","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"C Berthault, T Larcher, S H\u00e4rtle, et al.  \"Vet Res.\"  49, \"Atrophy of primary lymphoid organs induced by Marek's disease virus during early infection is associated with increased apoptosis, inhibition of cell proliferation and a severe B-lymphopenia.\" 31 (2018)","DOI":"10.1186\/s13567-018-0526-x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"KA Schat, CL Chen, BW Calnek, et al.  \"J Virol.\"  65, \"Transformation of T-lymphocyte subsets by Marek's disease herpesvirus.\" 1408 (1991)","DOI":"10.1128\/JVI.65.3.1408-1413.1991"},{"key":"3","doi-asserted-by":"crossref","unstructured":"S Reddy, Y Izumiya, B Lupiani,  \"Vet Microbiol.\"  206, \"Marek's disease vaccines: current status, and strategies for improvement and development of vector vaccines.\" 113 (2017)","DOI":"10.1016\/j.vetmic.2016.11.024"},{"key":"4","doi-asserted-by":"crossref","unstructured":"RL Witter  and LF Lee  \"Avian Pathol.\"  13, \"Polyvalent Marek's disease vaccines: safety, efficacy and protective synergism in chickens with maternal antibodies.\" 75 (1984)","DOI":"10.1080\/03079458408418510"},{"key":"5","doi-asserted-by":"crossref","unstructured":"BH Rispens, H Van Vloten, N Mastenbroek,  \"Avian Dis.\"  16, \"Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials.\" 108 (1972)","DOI":"10.2307\/1588905"},{"key":"6","doi-asserted-by":"crossref","unstructured":"K Atkins, A Read, N Savill, et al.  \"Evolution.\"  67, \"Vaccination and reduced cohort duration can drive virulence evolution: Marek's disease virus and industrialized agriculture.\" 851 (2013)","DOI":"10.1111\/j.1558-5646.2012.01803.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"B Lupiani, L Lee, X Cui, et al.  \"Proc Natl Acad Sci.\"  101, \"Marek's disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication.\" 11815 (2004)","DOI":"10.1073\/pnas.0404508101"},{"key":"8","doi-asserted-by":"crossref","unstructured":"A Brown, L Smith, L Kgosana, et al.  \"J Virol.\"  83, \"Homodimerization of the Meq viral oncoprotein is necessary for induction of T-cell lymphoma by Marek's disease virus.\" 11142 (2009)","DOI":"10.1128\/JVI.01393-09"},{"key":"9","doi-asserted-by":"crossref","unstructured":"L Lee, B Lupiani, R Silva, et al.  \"Vaccine.\"  26, \"Recombinant Marek's disease virus (MDV) lacking the Meq oncogene confers protection against challenge with a very virulent plus strain of MDV.\" 1887 (2008)","DOI":"10.1016\/j.vaccine.2008.01.046"},{"key":"10","doi-asserted-by":"crossref","unstructured":"R Silva, J Dunn, H Cheng, et al.  \"Avian Dis.\"  54, \"A MEQ-deleted Marek's disease virus cloned as a bacterial artificial chromosome is a highly efficacious vaccine.\" 862 (2010)","DOI":"10.1637\/9048-090409-Reg.1"},{"key":"11","doi-asserted-by":"crossref","unstructured":"L Lee, K Kreager, J Arango, et al.  \"Vaccine.\"  28, \"Comparative evaluation of vaccine efficacy of recombinant Marek's disease virus vaccine lacking Meq oncogene in commercial chickens.\" 1294 (2010)","DOI":"10.1016\/j.vaccine.2009.11.022"},{"key":"12","doi-asserted-by":"crossref","unstructured":"L Lee, K Kreager, M Heidari, et al.  \"Avian Dis.\"  57, \"Properties of a meq-deleted rMd5 Marek's disease vaccine: protection against virulent MDV challenge and induction of lymphoid organ atrophy are simultaneously attenuated by serial passage in vitro.\" 491 (2013)","DOI":"10.1637\/10388-092612-Reg.1"},{"key":"13","doi-asserted-by":"crossref","unstructured":"E Hildebrandt, J Dunn, H Cheng,  \"Avian Pathol.\"  44, \"Addition of a UL5 helicase-primase subunit point mutation eliminates bursal-thymic atrophy of Marek's disease virus \u0394Meq recombinant virus but reduces vaccinal protection.\" 254 (2015)","DOI":"10.1080\/03079457.2015.1041366"},{"key":"14","doi-asserted-by":"crossref","unstructured":"W Sacks, C Greene, D Aschman, et al.  \"J Virol.\"  55, \"Herpes simplex virus type 1 ICP27 is an essential regulatory protein.\" 796 (1985)","DOI":"10.1128\/JVI.55.3.796-805.1985"},{"key":"15","doi-asserted-by":"crossref","unstructured":"O Larralde, R Smith, G Wilkie, et al.  \"J Virol.\"  80, \"Direct stimulation of translation by the multifunctional herpesvirus ICP27 protein.\" 1588 (2006)","DOI":"10.1128\/JVI.80.3.1588-1591.2006"},{"key":"16","doi-asserted-by":"crossref","unstructured":"SJ Conrad, RF Silva, CJ Hearn, et al.  \"Virology.\"  516, \"Attenuation of Marek's disease virus by codon pair deoptimization of a core gene.\" 219 (2018)","DOI":"10.1016\/j.virol.2018.01.020"},{"key":"17","doi-asserted-by":"crossref","unstructured":"S Baker, A Nogales, L Martinez-Sobrido,  \"Future Virol.\"  10, \"Downregulating viral gene expression: codon usage bias manipulation for the generation of novel influenza A virus vaccines.\" 715 (2015)","DOI":"10.2217\/fvl.15.31"},{"key":"18","doi-asserted-by":"crossref","unstructured":"A Nogales, S Baker, E Ortiz-Riano, et al.  \"J Virol.\"  88, \"Influenza A virus attenuation by codon deoptimization of the NS gene for vaccine development.\" 10525 (2014)","DOI":"10.1128\/JVI.01565-14"},{"key":"19","doi-asserted-by":"crossref","unstructured":"A Zhou, Y Dang, M Zhou, et al.  \"Proc Natl Acad Sci.\"  113, \"Codon usage is an important determinant of gene expression levels largely through its effects on transcription.\" E6117 (2016)","DOI":"10.1073\/pnas.1606724113"},{"key":"20","doi-asserted-by":"crossref","unstructured":"T Quax, N Claassens, D S\u00f6ll, et al.  \"Mol Cell.\"  59, \"Codon bias as a means to fine-tune gene expression.\" 149 (2015)","DOI":"10.1016\/j.molcel.2015.05.035"},{"key":"21","doi-asserted-by":"crossref","unstructured":"M Niikura, T Kim, RF Silva, et al.  \"J Gen Virol.\"  92, \"Virulent Marek's disease virus generated from infectious bacterial artificial chromosome clones with complete DNA sequence and the implication of viral genetic homogeneity in pathogenesis.\" 598 (2011)","DOI":"10.1099\/vir.0.026864-0"},{"key":"22","doi-asserted-by":"crossref","unstructured":"BK Tischer, J von Einem, B Kaufer, et al.  \"Biotechniques.\"  40, \"Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli.\" 191 (2006)","DOI":"10.2144\/000112096"},{"key":"23","doi-asserted-by":"crossref","unstructured":"SA Rice  and DM Knipe  \"J Virol.\"  62, \"Gene-specific transactivation by herpes simplex virus type 1 alpha protein ICP27.\" 3814 (1988)","DOI":"10.1128\/JVI.62.10.3814-3823.1988"},{"key":"24","doi-asserted-by":"crossref","unstructured":"MD Koffa, JB Clements, E Izaurralde, et al.  \"EMBO J.\"  20, \"Herpes simplex virus ICP27 protein provides viral mRNAs with access to the cellular mRNA export pathway.\" 5769 (2001)","DOI":"10.1093\/emboj\/20.20.5769"},{"key":"25","doi-asserted-by":"crossref","unstructured":"S Tang, A Patel, PR Krause,  \"Proc Natl Acad Sci.\"  113, \"Herpes simplex virus ICP27 regulates alternative pre-mRNA polyadenylation and splicing in a sequence-dependent manner.\" 12256 (2016)","DOI":"10.1073\/pnas.1609695113"}],"container-title":["Avian Diseases"],"original-title":[],"deposited":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T03:38:49Z","timestamp":1611113929000},"score":1,"resource":{"primary":{"URL":"https:\/\/bioone.org\/journals\/avian-diseases\/volume-64\/issue-3\/aviandiseases-D-19-00166\/Codon-Deoptimization-of-UL54-in-meq-Deleted-Mareks-Disease-Vaccine\/10.1637\/aviandiseases-D-19-00166.full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,14]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1637\/aviandiseases-d-19-00166","relation":{},"ISSN":["0005-2086"],"issn-type":[{"value":"0005-2086","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1,14]]}}}